News

Filter

Sanofi-Synthelabo ups forecast on strong 1st-half, but fears persist over key patent

08-09-2003

French drugmaker Sanofi-Synthelabo says that it has upped its forecasts for the full year after posting…

AmbienApotexArixtraBristol-Myers SquibbClopidogrelDr Reddy's LaboratoriesEloxatinfondaparinuxNovartisOxaliplatin InjectionPlavixZolpidem Tartrate

Back to top